{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:51:49Z","timestamp":1782924709371,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"}],"funder":[{"DOI":"10.13039\/100017590","name":"Universit\u00e4tsklinikum Essen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017590","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bundesgesundheitsbl"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n                  <jats:p>Der Gebrauch leistungssteigernder Substanzen ist auch im Schachsport m\u00f6glich: F\u00fcr Stimulanzien zum kognitiven Doping wie Amphetamine, Methylphenidat, Modafinil und Ephedrin gibt es Hinweise auf eine gewisse Leistungssteigerung, allerdings auch auf negative Effekte im Hinblick auf Entscheidungsprozesse unter Zeitdruck. Die Substanzen stellen allgemein ein Gesundheitsrisiko dar; insbesondere bei \u00dcberdosierungen k\u00f6nnen sie das Herz-Kreislauf-System belasten oder psychotische Symptome ausl\u00f6sen. Grunds\u00e4tzlich besteht zudem das Risiko einer Abh\u00e4ngigkeit oder einer Funktion als \u201eEinstiegsdroge\u201c.<\/jats:p>\n                  <jats:p>Als anerkannte Sportart werden auch im organisierten Schach Dopingkontrollen durchgef\u00fchrt. Diese sind jedoch auf den Spitzensport beschr\u00e4nkt und entsprechend selten, weshalb bislang keine relevanten Dopingf\u00e4lle bekannt sind. Demgegen\u00fcber wird im Leistungs- und Amateursport eine h\u00f6here Pr\u00e4valenz sowohl bei Profis als auch bei Amateuren angenommen. Die gr\u00f6\u00dfere Gefahr f\u00fcr das Fairplay im Schach liegt jedoch in anderen betr\u00fcgerischen Methoden (Cheating, elektronisches Doping).<\/jats:p>","DOI":"10.1007\/s00103-026-04251-5","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T12:08:38Z","timestamp":1781179718000},"page":"780-783","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Doping im Schachsport","Doping in chess"],"prefix":"10.1007","volume":"69","author":[{"given":"Thomas E.","family":"Wessendorf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"4251_CR1","unstructured":"Nationale Anti Doping Agentur Deutschland: NADC21 Nationaler Anti Doping Code."},{"key":"4251_CR2","unstructured":"Deutscher Schachbund: https:\/\/www.schachbund.de\/schach-doping.html. Zugegriffen: 1. M\u00e4rz 2026"},{"key":"4251_CR3","volume-title":"G\u00f6tz von Berlichingen, II. Akt, 1. Szene","author":"JW Goethe","year":"1749","unstructured":"Goethe\u00a0JW (1749) G\u00f6tz von Berlichingen, II. Akt, 1. Szene"},{"key":"4251_CR4","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00103-010-1105-0","volume":"53","author":"AG Franke","year":"2010","unstructured":"Franke\u00a0AG, Lieb\u00a0K (2010) Pharmacological neuroenhancement and brain doping : Chances and risks. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 53:853\u2013859. https:\/\/doi.org\/10.1007\/s00103-010-1105-0","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"4251_CR5","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.euroneuro.2017.01.006","volume":"27","author":"AG Franke","year":"2017","unstructured":"Franke\u00a0AG, Gransmark\u00a0P, Agricola\u00a0A et\u00a0al (2017) Methylphenidate, modafinil, and caffeine for cognitive enhancement in chess: A double-blind, randomised controlled trial. Eur Neuropsychopharmacol 27:248\u2013260. https:\/\/doi.org\/10.1016\/j.euroneuro.2017.01.006","journal-title":"Eur Neuropsychopharmacol"},{"key":"4251_CR6","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1176\/appi.ajp.2009.09040472","volume":"166","author":"MS Gould","year":"2009","unstructured":"Gould\u00a0MS, Walsh\u00a0BT, Munfakh\u00a0JL et\u00a0al (2009) Sudden death and use of stimulant medications in youths. Am J Psychiatry 166:992\u20131001. https:\/\/doi.org\/10.1176\/appi.ajp.2009.09040472","journal-title":"Am J Psychiatry"},{"key":"4251_CR7","volume":"10","author":"O Bukstein","year":"2008","unstructured":"Bukstein\u00a0O (2008) Substance abuse in patients with attention-deficit\/hyperactivity disorder. Medscape J Med 10:24","journal-title":"Medscape J Med"},{"key":"4251_CR8","unstructured":"Praxis f\u00fcr Suchtmedizin: https:\/\/www.praxis-suchtmedizin.ch\/index.php\/de\/designerdrogen\/allgemeine-infos\/nachweisbarkeit. Zugegriffen: 1. M\u00e4rz 2026"},{"key":"4251_CR9","unstructured":"H\u00fcbner R (2008) Von der Willk\u00fcr der Dopingkontrollen. https:\/\/de.chessbase.com\/post\/robert-hbner-von-der-willkr-der-dopingkontrollen-. Zugegriffen: 1. Dez. 2025"},{"key":"4251_CR10","unstructured":"Svensen TJ (2026) Daniel Naroditsky\u2019s Death Ruled An Accident, Report By Medical Examiner Shows. https:\/\/www.chess.com\/news\/view\/report-reveals-daniel-naroditsky-probable-cause-of-death. Zugegriffen: 2. M\u00e4rz 2026"},{"key":"4251_CR11","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1592\/phco.26.10.1501","volume":"26","author":"CJ Teter","year":"2006","unstructured":"Teter\u00a0CJ, McCabe\u00a0SE, LaGrange\u00a0K, Cranford\u00a0JA, Boyd\u00a0CJ (2006) Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy 26:1501\u20131510. https:\/\/doi.org\/10.1592\/phco.26.10.1501","journal-title":"Pharmacotherapy"},{"key":"4251_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1055\/s-0033-1358682","volume":"47","author":"R Ott","year":"2014","unstructured":"Ott\u00a0R, Biller-Andorno\u00a0N (2014) Neuroenhancement among Swiss students--a comparison of users and non-users. Pharmacopsychiatry 47:22\u201328. https:\/\/doi.org\/10.1055\/s-0033-1358682","journal-title":"Pharmacopsychiatry"},{"key":"4251_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/phar.1166","volume":"33","author":"P Dietz","year":"2013","unstructured":"Dietz\u00a0P, Striegel\u00a0H, Franke\u00a0AG, Lieb\u00a0K, Simon\u00a0P, Ulrich\u00a0R (2013) Randomized response estimates for the 12-month prevalence of cognitive-enhancing drug use in university students. Pharmacotherapy 33:44\u201350. https:\/\/doi.org\/10.1002\/phar.1166","journal-title":"Pharmacotherapy"},{"key":"4251_CR14","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1097\/EDE.0000000000000737","volume":"28","author":"AG Franke","year":"2017","unstructured":"Franke\u00a0AG, Dietz\u00a0P, Ranft\u00a0K, Ballo\u00a0H, Simon\u00a0P, Lieb\u00a0K (2017) The Use of Pharmacologic Cognitive Enhancers in Competitive Chess. Epidemiology 28:e57\u2013e58. https:\/\/doi.org\/10.1097\/EDE.0000000000000737","journal-title":"Epidemiology"},{"key":"4251_CR15","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s10899-015-9576-4","volume":"32","author":"J Caballero","year":"2016","unstructured":"Caballero\u00a0J, Ownby\u00a0RL, Rey\u00a0JA, Clauson\u00a0KA (2016) Cognitive and performance enhancing medication use to improve performance in Poker. Journal of Gambling Studies 32:835\u2013845. https:\/\/doi.org\/10.1007\/s10899-015-9576-4","journal-title":"Journal of Gambling Studies"},{"key":"4251_CR16","doi-asserted-by":"crossref","unstructured":"Schubert M, G\u00fcre A, Haller N (2024) Performance-enhancement in esports \u2013 Players\u2019 perspectives on prevalence, legitimacy, governance and regulations. Performance Enhancement & Health 1210.1016\/j.peh.2024.100290","DOI":"10.1016\/j.peh.2024.100290"},{"key":"4251_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078702","volume":"8","author":"P Dietz","year":"2013","unstructured":"Dietz\u00a0P, Ulrich\u00a0R, Dalaker\u00a0R et\u00a0al (2013) Associations between physical and cognitive doping--a cross-sectional study in 2.997 triathletes. PLoS One 8:e78702. https:\/\/doi.org\/10.1371\/journal.pone.0078702","journal-title":"PLoS One"},{"key":"4251_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.peh.2025.100344","author":"K Schu","year":"2025","unstructured":"Schu\u00a0K, Haller\u00a0N (2025) Cheating and Doping in Chess \u2013 A Survey among 1,924 German Club Players using the Randomized Response Technique. Performance Enhancement & Health. https:\/\/doi.org\/10.1016\/j.peh.2025.100344","journal-title":"Performance Enhancement & Health"},{"key":"4251_CR19","unstructured":"Wikipedia: Igor Rausis. https:\/\/de.wikipedia.org\/wiki\/Igor_Rausis. Zugegriffen: 8. M\u00e4rz 2026"},{"key":"4251_CR20","unstructured":"Wikipedia: Betrugsf\u00e4lle im Schach. https:\/\/de.wikipedia.org\/wiki\/Betrugsf%C3%A4lle_im_Schach. Zugegriffen: 14. Dez. 2025"}],"container-title":["Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-026-04251-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00103-026-04251-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-026-04251-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:04:27Z","timestamp":1782921867000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00103-026-04251-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["4251"],"URL":"https:\/\/doi.org\/10.1007\/s00103-026-04251-5","relation":{},"ISSN":["1436-9990","1437-1588"],"issn-type":[{"value":"1436-9990","type":"print"},{"value":"1437-1588","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"T.E.\u00a0Wessendorf gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden vom Autor keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}